A PPARγ, NF-κB and AMPK-Dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver

Molecules

Volumn 19, Issue 6, 2014, Pages 8289-8302

  Jiménez Flores, Lizbeth M ^a   López Briones, Sergio ^a   Macías Cervantes, Maciste H ^a   Ramírez Emiliano, Joel ^a   Pérez Vázquez, Victoriano ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Antioxidants; Curcuma longa; Diabetes; Inflammation; Obesity; Polyphenols

Indexed keywords

CURCUMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL; DIABETES MELLITUS; DRUG EFFECTS; LIVER; MALE; METABOLISM; MOUSE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CURCUMIN; DIABETES MELLITUS; LIVER; MALE; MICE; NF-KAPPA B; PPAR GAMMA;

EID: 84903289244     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19068289     Document Type: Article

References (56)

1. Gupta S.C.; Patchva S.; Koh W.; Aggarwal B.B. Discovery of curcumin a component of golden spice and its miraculous biological activi ties. Clin. Exp. Pharmacol. Physiol. 2012 39 283-299.
2. Sharma R.A.; Gescher A.J.; Steward W.P. Curcumin: The story so far. Eur. J. Cancer 2005 41 1955-1968.
3. Shishodia S. Molecular mechanisms of curcumin action: Gene expression. Biofactors 2012 39 37-55.
4. Pescosolido N.; Giannotti R.; Plateroti A.M.; Pascarella A.; Nebbioso M. Curcumin: Therapeutical potential in ophthalmology. Planta Med. 2014 80 249-254.
5. Shehzad A.; Ha T.; Subhan F.; Lee Y.S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 2011 50 151-161.
6. Bradford P.G. Cur cumin and obesity. Biofactors 2013 39 78-87.
7. Aggarwal B.B.; Young-Joon S.; Shishodia S. Molecular targets and therapeutic uses of curcu min in health and disease. In Advances in Experimental Medicine and Biology; Bharat B. Aggarwal Y.J.S. Shishir S. Eds; Springer US: New York NY USA 2007; Volume 595 pp. 227-243.
8. Zhang D.W.; Fu M.; Gao S.H.; Liu J.L. Curcumin and diabetes: A systematic review. Evid. Based Complement. Alternat. Med. 2013 2013 636-653.
9. International Diabetes Federation. IDF Diabetes Atlas 6t h ed.; International Diabetes Federation: Brussels Belgium 2013. Available online: http://www.idf.org/diabetesatlas (accessed on 17 June 2014).
10. Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 2014 5 e996.
11. Vera-Ramirez L.; Perez-Lopez P.; Varela-Lopez A.; Ramirez-Tortosa M.; Battino M.; Quiles J.L. Curcumin and liver disease. Biofactors 2013 39 88-100.
12. Martinez-Morua A.; Soto-Urquieta M.G.; Franco-Robles E.; Zuniga-Trujillo I.; Campos-Cervantes A.; Perez-Vazquez V.; Ramirez-Emiliano J. Curcumin decreases oxidative stress in m itochondria isolated from liver and kidneys of high-fat diet-induced obese mice. J. Asian Nat. Prod. Res. 2013 15 905-915.
13. Franco-Robles E.; Campos-Cervantes A.; Murillo-Ortiz B.O.; Segovia J.; Lopez-Briones S.; Vergara P.; Perez-Vazquez V.; Solis-Ortiz M.S.; Ramirez-Emiliano J. Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes. Appl. Physiol. Nutr. Metab. 2014 39 211-218.
14. Singh S.; Aggarwal B.B. Activation of transcription factor nf-kappa b is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995 270 24995-25000.
15. Ejaz A.; Wu D.; Kwan P.; Meydani M. Curcumin inhibits adipogenesis in 3t3-l1 adipocytes and angiogenesis and obesity in c57/bl mice. J. Nutr. 2009 139 919-925.
16. Yang Y.; Duan W.; Lin Y.; Yi W.; Liang Z.; Yan J.; Wang N.; Deng C.; Zhang S.; Li Y.; et al. Sirt1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischem ia reperfusion injury. Free Radic. Biol. Med. 2013 65 667-679.
17. Picard F.; Auwerx J. Ppar(gamma) and glucose homeostasis. Annu. Rev. Nutr. 2002 22 167-197.
18. Rodgers J.T.; Lerin C.; Haas W.; Gygi S.P.; Spiegelman B.M.; Puigserver P. Nutrient control of glucose homeostasis through a complex of pgc-1alpha and sirt1. Nature 2005 434 113-118.
19. Ren X.Y.; Li Y.N.; Qi J.S.; Niu T. Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J. Diabetes Complicat. 2008 22 357-364.
20. Seo K.I.; Choi M.S.; Jung U.J.; Kim H.J.; Yeo J.; Jeon S.M.; Lee M.K. Effect of curcumin supplementation on blood glucose plasma insulin and glucose homeostasis related enzyme activities in diabetic db/db mic e. Mol. Nutr. Food Res. 2008 52 995-1004.
21. Coleman D.L. Hummel K.P. Studies with the mutation diabetes in the mouse Diabetologia 1967 3 238-248.
22. We isberg S.P.; Leibel R.; Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008 149 3549-3558.
23. He H.J.; Wang G.Y.; Gao Y.; Ling W.H.; Yu Z.W.; Jin T.R. Curcumin attenuates Nrf2 signaling defect oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes 2012 3 94-104.
24. Steigerwalt R.; Nebbioso M.; Appendino G.; Belcaro G.; Ciammaichella G.; Cornelli U.; Luzzi R.; Togni S.; Dugall M.; Cesarone M.R.; et al. Meriva(r) a lecithinized curcumin delivery system in diabetic microangiopathy and retinopathy. Panminerva Med. 2012 54 11-16.
25. Dalboge L.S.; Almholt D.L.; Neerup T.S.; Vassiliadis E.; Vrang N.; Pedersen L.; Fosgerau K.; Jelsing J. Characterisation of age-dependent beta cell dynamics in the male db/db mice. PLoS One 2013 8 e82813.
26. Arkan M.C.; Hevener A.L.; Greten F.R.; Maeda S.; Li Z.W.; Long J.M.; Wynshaw-Boris A.; Poli G.; Olefsky J.; Karin M. Ikk-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005 11 191-198.
27. Cai D.; Yuan M.; Frantz D.F.; Melendez P.A.; Hansen L.; Lee J.; Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of ikk-beta and nf-kappab. Nat. Med. 2005 11 183-190.
28. Steinberg G.R.; Kemp B.E. Ampk in health and disease. Physiol. Rev. 2009 89 1025-1078.
29. Zang M.; Xu S.; Maitland-Toolan K.A.; Zuccollo A.; Hou X.; Jiang B.; Wierzbicki M.; Verbeuren T.J.; Cohen R.A. Polyphenols stimulate amp-activated protein kinase lower lipids and inhibit accelerated atherosclerosis in diabetic ldl receptor-deficient mice. Diabetes 2006 55 2180-2191.
30. Oakhill J.S.; Scott J.W.; Kemp B.E. Ampk functions as an adenylate charge-regulated protein kinase. Trends Endocrinol. Metab. 2012 23 125-132.
31. Yu X.; McCorkl e S.; Wang M.; Lee Y.; Li J.; Saha A.K.; Unger R.H.; Ruderman N.B. Leptinomimetic effects of the amp kinase activator aicar in leptin-resistant rats: Prevention of diabetes and ectopic lipid deposition. Diabetologi a 2004 47 2012-2021.
32. Hou X.; Xu S.; Maitland-Toolan K.A.; Sato K.; Jiang B.; Ido Y.; Lan F.; Walsh K.; Wierzbicki M.; Verbeuren T.J.; et al. Sirt1 regulates hepatocyte lipid metabolism through activating amp-activated protein kinase. J. Biol. Chem. 2008 283 20015-20026.
33. Lan F.; Cacicedo J.M.; Ruderman N.; Ido Y. Sirt1 modulation of the acetylation status cytosolic localization and activity of lkb1. Possible role in amp-activated protein kinase activation. J. Biol. Chem. 2008 283 27628-27635.
34. De Kreutzenberg S.V.; Ceolotto G.; Papparella I.; Bortoluzzi A.; Semplicini A.; Dalla Man C.; Cobelli C.; Fadini G.P.; Avogaro A. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes 2010 59 1006-1015.
35. Gillum M.P.; Kotas M.E.; Erion D.M.; Kursaw e R.; Chatterjee P.; Nead K.T.; Muise E.S.; Hsiao J.J.; Frederick D.W.; Yonemitsu S.; et al. Sirt1 regulates adipose tissue inflammation. Diabetes 2011 60 3235-3245.
36. Fr öjdö S.; Durand C.; Molin L.; Carey A.L.; El-Osta A.; Kingwell B.A.; Febbraio M.A.; Solari F.; Vidal H.; Pirola L. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insul in signaling pathway by sirt1. Mol. Cell. Endocrinol. 2011 335 166-176.
37. Ruderman N.B.; Xu X.J.; Nelson L.; Cacicedo J.M.; Saha A.K.; Lan F.; Ido Y. Ampk and sirt1: A long-stan ding partnership? Am. J. Physiol. Endocrinol. Metab. 2010 298 E751-E760.
38. Sansone L.; Reali V.; Pellegrini L.; Villanova L.; Aventaggiato M.; Marfe G.; Rosa R.; Nebbioso M.; Tafani M.; Fini M.; et al. Sirt1 silencing confers neuroprotection through igf-1 pathway activation. J. Cell. Physiol. 2013 228 1754-1761.
39. Chung S.; Yao H.; Caito S.; Hwang J.W .; Arunachalam G.; Rahman I. Regulation of sirt1 in cellular functions: Role of polyphenols. Arch. Biochem. Biophys. 2010 501 79-90.
40. Lomb D.J.; Laurent G.; Haigis M.C. Sirtuins regulate key aspects of lipid metabolism. Biochim. Biophys. Acta (BBA)-Proteins Proteomics 2010 1804 1652-1657.
41. Puigserver P.; Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 a lpha (pgc-1 alpha): Transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003 24 78-90.
42. Patti M.E.; Butte A.J.; Crunkhorn S.; Cusi K.; Berria R.; Kashyap S.; Miyazaki Y.; Kohane I.; Costello M.; Saccone R.; et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of pgc1 and nrf1. Proc. Natl. Acad. Sci. USA 2003 100 8466-8471.
43. Wright D.C. Han D.H. Garcia-Roves P.M. Geiger P.C. Jones T.E. Holloszy J.O Exercise-induced mitochondrial biogenesis begins before the increase in muscle pgc-1alpha expression. J. Biol. Chem. 2007 282 194-199.
44. Nandi A.; Kitamura Y.; Kahn C.R.; Accili D. Mouse models of insulin resistance. Physiol. Rev. 2004 84 623-647.
45. Galli A.; Crabb D.; Price D.; Ceni E.; Salzano R.; Surrenti C.; Casini A. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation o f human hepatic stellate cells. Hepatology 2000 31 101-108.
46. Marra F.; Efsen E.; Romanelli R.G.; Caligiuri A.; Pastacaldi S.; Batignani G.; Bonacchi A.; Caporale R.; La ffi G.; Pinzani M.; et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000 119 466-478.
47. Miyahara T.; Schrum L.; Rippe R.; Xiong S.; Yee H.F. Jr.; Motomura K.; Anania F.A.; Willson T.M.; Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activati on. J. Biol. Chem. 2000 275 35715-35722.
48. Lin J.; Tang Y.; Kang Q.; Feng Y.; Chen A. Curcumin inhibits gene expression of receptor for advanced glycation end-products (rage) in hepatic s tellate cells in vitro by elevating ppargamma activity and attenuating oxidative stress. Br. J. Pharmacol. 2012 166 2212-2227.
49. Xu J.; Fu Y.; Chen A. Activation of peroxisome proliferator-activat ed receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 2003 285 G20-G30.
50. Ferroni P.; Della-Morte D.; Pileg gi A.; Riondino S.; Rundek T.; Ricordi C.; Guadagni F. Pleiotropic effects of ppargamma agonist on hemostatic activation in type 2 diabetes mellitus. Curr. Vasc. Pharmacol. 2013 11 338-351.
51. Ishii N.; Carmines P.K.; Yokoba M.; Imaizumi H.; Ichikawa T.; Ikenagasa H.; Kodera Y.; Oh-Ishi M.; Aoki Y.; Maeda T.; et al. Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats. Clin. Sci. 2013 124 543-552.
52. Kolodziejczyk J.; Olas B.; Saluk-Juszczak J.; Wachowicz B. Antioxidative properties of curcumin in the protection of blood platelets against oxidative stress in vitro. Platelets 2011 22 270-2 76.
53. Mythri R.B.; Harish G.; Dubey S.K.; Misra K.; Bharath M.M. Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: Implications for parkinson's disease. Mol. cell. Biochem. 2011 347 135-143.
54. Hurkman W.J.; Tanaka C.K. Solubilization of plant membrane proteins for analysis by two-dimensional gel electrophoresis. Plant Physiol. 1986 81 802-806.
55. Encarnació n S.; Hernández M.; Martínez-Batallar G.; Contreras S.; Vargas Mdel C.; Mora J. Comparative proteomics using 2-D gel electrophoresis and mass spectrometry as tools to dissect stimulons and regulons in bacteria with sequenced or partially sequenced genomes. Biol. Proced. Online 2005 7 117-135.
56. Lowry O.H.; Ro sebrough N.J.; Farr A.L.; Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951 193 265-275.